Urinary Tract Infection Treatment Market Set to Expand Saliently at a Robust CAGR during the Forecast Period 2018-2026

Urinary Tract Infection (UTI) is caused when bacteria enters the urethra and infects the urinary bladder, causing severe health issues. UTI infections are common health problems in females than in males with biologic factors accounting as the major cause. Antibiotics are usually the first line of treatment prescribed by doctors for urinary tract infections. According to the site of manifestation by the microbe, infections are classified as cystitis (bladder), urethritis (urethra), prostatitis (prostate) or pyelonephritis (kidney). Painful and increased frequency of urination, excessive and involuntary passing of urine at night are the common symptoms associated with UTI. Hospitalized patients using urinary catheters are at a higher risk for developing UTI.

Download PDF Brochure of Research Report:

Market Taxonomy:

The ****** urinary tract infection treatment market is segmented on the basis of drug type, indications, distribution channel, and geography.

On the basis of drug type, the ****** urinary tract infection treatment market is segmented into:

  • Nitrofurans
  • Sulphonamides
  • Quinolones
  • Azoles and Amphotericin B
  • Aminoglycoside antibiotics
  • Tetracycline
  • Others

On the basis of indication, the ****** urinary tract infection treatment market is segmented into:

  • Complicated UTI
  • Uncomplicated UTI
  • Recurring Complicated UTI

On the basis of distribution channel, the ****** urinary tract infection market is segmented into:

  • Hospital Pharmacies
  • e-Pharmacies
  • Retail Pharmacies

Market Key Players:-

Cipla Ltd., Johnson & Johnson, Bayer AG, Pfizer Inc., GlaxoSmithKline, Boehringer Ingelheim, F. Hoffmann-La Roche Ltd., Novartis AG AstraZeneca Plc, and Roche Ltd.

Request Customization:


About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave,
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com 

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.